Cargando…

ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)

INTRODUCTION: Breast cancer surgery aims to excise lesions with clear margins and provide optimal cosmesis with a low re‐excision rates. These aims are aided by accurate lesion localisation and a surgical choice of incision site with minimal removal of healthy tissue. Problems associated with hookwi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourke, Anita G, Taylor, Donna, Saunders, Christobel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084208/
https://www.ncbi.nlm.nih.gov/pubmed/35527346
http://dx.doi.org/10.1111/1754-9485.13418
_version_ 1785021690211729408
author Bourke, Anita G
Taylor, Donna
Saunders, Christobel
author_facet Bourke, Anita G
Taylor, Donna
Saunders, Christobel
author_sort Bourke, Anita G
collection PubMed
description INTRODUCTION: Breast cancer surgery aims to excise lesions with clear margins and provide optimal cosmesis with a low re‐excision rates. These aims are aided by accurate lesion localisation and a surgical choice of incision site with minimal removal of healthy tissue. Problems associated with hookwires have led to adoption of non‐wire methods including radioguided occult lesion localisation using iodine‐125 (ROLLIS). This paper outlines the problems encountered and lessons learnt during the largest RCT involving 659 participants, conducted at eight sites (seven Australian, one New Zealand centres) between September 2013 and April 2018.* METHODS: Data, along with substantive comments, regarding each ROLLIS procedure, documenting each step from the seed insertion, ease of operative retrieval, to return of the seed to medical physics, from a shared on‐line secure database and a separate site email survey, were synthesised and categorised. RESULTS: The Australian and New Zealand ROLLIS RCT experience highlights several important issues. Lessons learned were related to licencing the seed and tracking protocols. A Designated Team Lead, who is a good communicator, ensuring the Tracking Protocols were accurately followed and updated, subspecialty leads and a Co‐ordinator, responsible for training, logbook maintenance and seed ordering, enhanced the success and acceptance of the programme. Addressing radiation issues, fears, education of staff and seed loss was imperative. CONCLUSION: The Australian and New Zealand ROLLIS RCT experience highlights the need for adherence to local licencing laws and protocols, appointing a dedicated ROLLIS Designated Team Lead with good communication and a ROLLIS Co‐ordinator. These facilitate the adoption of a successful ROLLIS programme.
format Online
Article
Text
id pubmed-10084208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100842082023-04-11 ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS) Bourke, Anita G Taylor, Donna Saunders, Christobel J Med Imaging Radiat Oncol MEDICAL IMAGING INTRODUCTION: Breast cancer surgery aims to excise lesions with clear margins and provide optimal cosmesis with a low re‐excision rates. These aims are aided by accurate lesion localisation and a surgical choice of incision site with minimal removal of healthy tissue. Problems associated with hookwires have led to adoption of non‐wire methods including radioguided occult lesion localisation using iodine‐125 (ROLLIS). This paper outlines the problems encountered and lessons learnt during the largest RCT involving 659 participants, conducted at eight sites (seven Australian, one New Zealand centres) between September 2013 and April 2018.* METHODS: Data, along with substantive comments, regarding each ROLLIS procedure, documenting each step from the seed insertion, ease of operative retrieval, to return of the seed to medical physics, from a shared on‐line secure database and a separate site email survey, were synthesised and categorised. RESULTS: The Australian and New Zealand ROLLIS RCT experience highlights several important issues. Lessons learned were related to licencing the seed and tracking protocols. A Designated Team Lead, who is a good communicator, ensuring the Tracking Protocols were accurately followed and updated, subspecialty leads and a Co‐ordinator, responsible for training, logbook maintenance and seed ordering, enhanced the success and acceptance of the programme. Addressing radiation issues, fears, education of staff and seed loss was imperative. CONCLUSION: The Australian and New Zealand ROLLIS RCT experience highlights the need for adherence to local licencing laws and protocols, appointing a dedicated ROLLIS Designated Team Lead with good communication and a ROLLIS Co‐ordinator. These facilitate the adoption of a successful ROLLIS programme. John Wiley and Sons Inc. 2022-05-08 2022-12 /pmc/articles/PMC10084208/ /pubmed/35527346 http://dx.doi.org/10.1111/1754-9485.13418 Text en © 2022 The Authors. Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Radiologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle MEDICAL IMAGING
Bourke, Anita G
Taylor, Donna
Saunders, Christobel
ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
title ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
title_full ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
title_fullStr ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
title_full_unstemmed ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
title_short ROLLIS roll‐out: Pitfalls, errors, lessons learned and recommendations from Australian and New Zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)I) seed (ROLLIS)
title_sort rollis roll‐out: pitfalls, errors, lessons learned and recommendations from australian and new zealand experience during the randomised controlled trial, implementing a novel localisation method for impalpable malignant breast lesions, radio‐guided occult lesion localisation with iodine‐125 ((125)i) seed (rollis)
topic MEDICAL IMAGING
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084208/
https://www.ncbi.nlm.nih.gov/pubmed/35527346
http://dx.doi.org/10.1111/1754-9485.13418
work_keys_str_mv AT bourkeanitag rollisrolloutpitfallserrorslessonslearnedandrecommendationsfromaustralianandnewzealandexperienceduringtherandomisedcontrolledtrialimplementinganovellocalisationmethodforimpalpablemalignantbreastlesionsradioguidedoccultlesionlocalisationwithiodine125125ise
AT taylordonna rollisrolloutpitfallserrorslessonslearnedandrecommendationsfromaustralianandnewzealandexperienceduringtherandomisedcontrolledtrialimplementinganovellocalisationmethodforimpalpablemalignantbreastlesionsradioguidedoccultlesionlocalisationwithiodine125125ise
AT saunderschristobel rollisrolloutpitfallserrorslessonslearnedandrecommendationsfromaustralianandnewzealandexperienceduringtherandomisedcontrolledtrialimplementinganovellocalisationmethodforimpalpablemalignantbreastlesionsradioguidedoccultlesionlocalisationwithiodine125125ise